# Tolcapone Treatment of Pathological Gambling

> **NCT00927563** · PHASE2 · COMPLETED · sponsor: **University of Chicago** · enrollment: 24 (actual)

## Conditions studied

- Pathological Gambling

## Interventions

- **DRUG:** Tolcapone

## Key facts

- **NCT ID:** NCT00927563
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-05
- **Final completion:** 2012-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927563, "Tolcapone Treatment of Pathological Gambling". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00927563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*